Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clinical Trial ID NCT00935792

PubWeight™ 2.96‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00935792

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacol Rev 2013 1.25
2 Antigenic modulation and rituximab resistance. Semin Hematol 2010 0.92
3 Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach. Leuk Lymphoma 2011 0.90
Next 100